Financials data is unavailable for this security.
View more
Year on year Pharmx Technologies Ltd had net income fall 68.32% from a loss of 1.05m to a larger loss of 1.77m despite a 10.67% increase in revenues from 6.13m to 6.78m. An increase in the selling, general and administrative costs as a percentage of sales from 72.61% to 81.95% was a component in the falling net income despite rising revenues.
| Gross margin | 81.80% |
|---|---|
| Net profit margin | 1.40% |
| Operating margin | 3.60% |
| Return on assets | 0.29% |
|---|---|
| Return on equity | 0.50% |
| Return on investment | 0.45% |
More ▼
Cash flow in AUDView more
In 2024, Pharmx Technologies Ltd did not generate a significant amount of cash. However, the company earned 3.21m from its operations for a Cash Flow Margin of 47.26%. In addition the company generated 1.75m cash from investing, though they paid out 4.62m more in financing than they received.
| Cash flow per share | 0.0022 |
|---|---|
| Price/Cash flow per share | 21.67 |
| Book value per share | 0.0267 |
|---|---|
| Tangible book value per share | 0.0051 |
More ▼
Balance sheet in AUDView more
| Current ratio | 1.37 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.015 |
|---|---|
| Total debt/total capital | 0.0148 |
More ▼
Growth rates in AUD
Year on year, growth in earnings per share excluding extraordinary items increased 110.81%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 107.35 |
